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Abstract 3 
A new phenomenological mathematical model based directly on laboratory data for thrombin 4 
generation and having a patient-specific character is described. A set of the solved equations 5 
for cell-based models of blood coagulation that can reproduce the temporal evolution of 6 
thrombin generation is proposed; such equations are appropriate for use in Computational 7 
Fluid Dynamics (CFD) simulations. The initial values for the reaction rates are either taken 8 
from already existing model or experimental data, or they can be obtained from simple 9 
reasoning under certain assumptions; it is shown that coefficients can be adjusted in order to 10 
fit a range of different thrombin generation curves as derived from thrombin generation 11 
assays. The behaviour of the model for different platelet concentration seems to be in good 12 
agreement with reported experimental data. It is shown that the reduced set of equations used 13 
represents to a good approximation a low-order model of the detailed mechanism and thus it 14 
can represent a cost-effective and-case specific mathematical model of coagulation reactions 15 
up to thrombin generation  16 
Keywords: 17 
CFD, coagulation, simulation, thrombus 18 
 19 
Introduction 20 
The formation of thrombus in blood is involved in a number of life threatening situations like 21 
Coronary Artery Disease and mechanical heart valve complications; it is a multi-scale 22 
phenomenon both in respect of time and space, involving a number of biochemical 23 
substances, blood circulating minerals and cellular responses. While the formation of blood 24 
clot is a physiological response of human body to vessel injury, it can be initiated when blood 25 
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contacts certain substances like those exposed after the rupture of atheromatous plaques in 26 
stenosed vessels [Rauch, Osende et al. 2001] and when pathological flow conditions prevail 27 
in a region [Nesbitt, Westein et al. 2009]. Between the initiation and the formation of a 28 
thrombus, a series of enzymatic reactions takes place also known as coagulation cascade 29 
[Furie and Furie 2008], classically divided in three parts: (1) the extrinsic or Tissue Factor 30 
(TF) pathway, (2) the intrinsic or contact pathway and the (3) common pathway. In every 31 
step of the process a circulating zymogen is activated, with the activation reaction being 32 
catalysed by the products of previous steps. However, as most of these enzymatic reactions 33 
take place on cell membranes, the current approaches for coagulation are cell-based models 34 
and the process is divided in three discrete phases, initiation, amplification and propagation. 35 
Thrombin (factor IIa) and platelets play critical roles in the coagulation process. Thrombin in 36 
the final step catalyses the conversion of fibrinogen (factor I) to fibrin (factor Ia), a protein 37 
that through polymerization creates a mesh clot that also traps circulating blood cells. In 38 
addition, thrombin activates factor XIII (that forms bonds that crosslink the fibrin strands 39 
[Mosesson 2005]), causes the activation of platelets [Brass 2003], the activation of factors V 40 
and VIII and their inhibitor protein C (APC). Platelets on the other hand, after activation by 41 
chemical or mechanical stimulation [Jesty, Yin et al. 2003] become adhesive and form 42 
aggregates on the materials exposed after arterial damage [Badimon, Badimon et al. 1986] or 43 
plaque rapture [Fernández-Ortiz, Badimon et al. 1994; Reininger, Bernlochner et al. 2010] or 44 
in flowing blood. In addition they play a major role in thrombin formation [Rosing, van Rijn 45 
et al. 1985; Monroe, Hoffman et al. 2002] and they enhance the coagulation process by 46 
supporting on their membrane some of the coagulation reactions [Smith 2009], releasing 47 
chemical substances and micro-particles [Rendu and Brohard-Bohn 2001] that influence the 48 
progress of coagulation and activate other platelets.  49 
The advance of computational techniques and increase of computational power have made 50 
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possible the emergence of in silico studies that reproduce a part of or the whole process in 51 
greater or lesser detail, simulating either the whole process of thrombus formation or only the 52 
coagulation reaction system up to thrombin or fibrin production. The first mathematical 53 
simulation of thrombin and fibrin generation in plasma used exponential time functions as 54 
fixed inputs for concentration of some enzymes [Willems, Lindhout et al. 1991]. In vitro 55 
measurements of the reaction rate constants [Lawson, Kalafatis et al. 1994] were used for the 56 
development of a system of 20 reactions, including formation and breakage of complexes, in 57 
a study that mainly focused on the effect of variation of the concentration of different factors 58 
[Jones and Mann 1994]. A similar model was proposed for the intrinsic pathway including 59 
fibrin production and APC inhibition mechanism, and was used to investigate threshold 60 
values for some enzymes and the spatial propagation of coagulation from the reacting site due 61 
to diffusion [Zarnitsina, Pokhilko et al. 1996; Zarnitsina, Pokhilko et al. 1996]. Subsequent 62 
work included more chemical substances and biochemical processes [Hockin, Jones et al. 63 
2002] up to thrombin production, resulting in a system consisting of 27 reactions and 42 64 
reaction rate constants that later was combined with a Monte Carlo simulation method, in 65 
order to detect changes to the cascade initiation behaviour, due to small variation of the 66 
concentration of enzymes induced by the stochastic approach [Lo, Denney et al. 2005]. At the 67 
same time some studies used simulations to investigate a specific part of the coagulation 68 
cascade, as the function of positive feedback loops and threshold concentrations for cascade 69 
initiation[Beltrami and Jesty 1995], the triggering threshold with respect to Tissue Factor 70 
Pathway Inhibitor (TFPI) [Xu, Hu Xu et al. 2005] or the inhibition mechanism of APC [Qiao, 71 
Xu et al. 2004].  72 
The studies that simulate thrombus formation and growth, simultaneously with blood flow 73 
and concentration of related substances, necessitate a less detailed sub-model for the 74 
coagulation cascade. While for the first studies of this kind the production rates of substances 75 
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were mainly modelled as fluxes or with the use of few reactions [Hubbell and McIntire 1986; 76 
Folie and McIntire 1989], the increase of computational power allowed more complicated 77 
multi-scale and multi-phase models to emerge, that include an integrated coagulation sub-78 
model. The authors of [Kuharsky and Fogelson 2001] proposed an integrated model of 79 
thrombus formation under flow conditions, taking into account the localization of reactions 80 
on surfaces, with the inclusion of the available binding sites on cell membranes for enzymes 81 
and using a system of 59 equations to simulate the coagulation system up to thrombin 82 
generation. A study that modelled platelet-platelet and platelet-wall interaction as reversible 83 
elastic links demonstrated the influence of these interactions on  the flow field and predicted 84 
thrombus evolution and emboli formation [Fogelson and Guy 2004]. The initial model was 85 
later improved with the addition of the APC mechanism and the transport of substances 86 
between plasma and endothelium cells [Fogelson and Tania 2005]. The same concepts for 87 
cells and reactions were combined with an immersed boundary method [Lai and Peskin 2000; 88 
Peskin 2002] for modelling platelet movement and the interaction between platelet membrane 89 
sites and chemicals or endothelium. The results of this micro-scale model were also used to 90 
develop a continuous model for platelet aggregation (with platelets as continuous phase with 91 
movement limitations) describing the alterations in blood flow due to the presence of 92 
aggregated platelets [Fogelson and Guy 2008]. The macro-scale model was tested in 93 
simulations with pulsating flow in an idealized two dimensional vessel bifurcation [Yang, 94 
Lewis et al. 2004]. The continuous model, with coupling of flow with thrombus growth and 95 
including flow and transport within the thrombus, was used to demonstrate the effects of flow 96 
conditions and the quantity of TF exposed in thrombus growth [Leiderman and Fogelson 97 
2011]. Anand et al [Anand, Rajagopal et al. 2003; Anand, Rajagopal et al. 2005] presented 98 
another multi-process model that used a viscoelastic model to simulate flow for both free 99 
vessel lumen and clot. This model also incorporated the activation of platelets due to 100 
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excessive shear stress and fibrin production and lysis. In a similar work, a model for the 101 
viscosity of blood depending on fibrin concentration was proposed and used in a three-102 
dimensional simulation of blood coagulation in a tube with a reacting site; in this study the 103 
area where fibrin concentration exceeded a specific value interpreted as the area occupied by 104 
the clot[Bodnár and Sequeira 2008]. In [Xu, Chen et al. 2008] another multi-scale model was 105 
proposed that included a cellular pot model [Marée, Grieneisen et al. 2007] for discrete cells 106 
and cell movement was simulated through an energy-based stochastic process. The 107 
simulation involved differentiation of cell movements depending on fibrin levels and cell-cell 108 
or cell-surface interaction and bonds. The model was used to evaluate the role of fVII in 109 
venous thrombus formation due to vessel injury [Xu, Lioi et al. 2010] and to examine the 110 
impact of pulsating flow and the non-Newtonian characteristics of blood on thrombus growth 111 
[Xu, Chen et al. 2009].  112 
While the detailed description of coagulation included in these works makes them appropriate 113 
for studying the influence of different factors, unfortunately it increases dramatically the 114 
computational cost; thus published applications mainly refer to small two dimensional 115 
regions (~100μm) while the dimensions of computational regions for studying thrombus 116 
formation in a coronary artery or in mechanical heart valves are much larger (typically, the 117 
diameter of the coronary artery is about 4mm while the diameter of the aortic root is of some 118 
cm) with the flow distribution being three-dimensional and strongly time dependent 119 
preventing use of simplified flow models. In addition, these models do not have patient-120 
specific characteristics, as the use of reaction rate constants derived from experiments do not 121 
allow the significant variability of thrombin generation observed for different individuals 122 
[Oliver, Monroe et al. 1999]. At the same time, it has been shown that the resulting thrombin 123 
generation curve predicted by such models under steady state conditions can be simulated in 124 
different ways by a much simpler system of 6 equations [Wagenvoord, Hemker et al. 2006]. 125 
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As the process between the initial stimulation and the formation of thrombin consist the main 126 
part of the coagulation reactions, our motivation is to develop a phenomenological model for 127 
thrombin formation that would be efficient enough to be used with three dimensional 128 
Computational Fluid Dynamic (CFD) simulations while also being adjustable in order to 129 
reflect measured differences existing in data of different individuals. A case-specific 130 
simplified model like this, though not including the full biochemical details of the process, 131 
could be used for comparison of different cases of clinical interest.  132 
Materials and methods 133 
The aim of the study is to propose a set of equations that describe the thrombin generation in 134 
blood using the minimum possible number of parameters but which are able to describe with 135 
acceptable accuracy the whole process. The model is validated against experimental results 136 
for thrombin generation in vitro from Thrombin Generation Assays (TGA). The proposed 137 
model for thrombin production is based on the cell-based models of coagulation[Smith 2009]; 138 
the full description of the biochemical processes are mainly based on [Hoffman and Monroe 139 
2001]. For a detailed modelling of coagulation the localization of the different reactions 140 
makes the task more complicated, as it requires taking into account additional parameters 141 
such as the binding rate of the substances on cell membranes and the expression, 142 
concentration and availability of appropriate binding sites on the cell surfaces. For the 143 
development of a simplified model however, it can function as an advantage, as the processes 144 
can be grouped in respect to the location they occur (on platelet surface, on the vessel wall or 145 
in plasma). This approach is rigorous in cases where the transport of reactants is mainly due 146 
to convection such as arterial flow conditions, or in cases where the different species are well 147 
mixed. The generation of thrombin and generally the coagulation process is mainly attributed 148 
to activated platelets, while the initiation phase is localized on the reacting site of the vessel 149 
surface. The burst of thrombin generation is considered to occur when the small amounts of 150 
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thrombin produced during the initiation phase cause thrombin concentration to exceed a 151 
threshold value. The threshold values used are within the range of thrombin concentration 152 
values that have been reported in [Rosing, van Rijn et al. 1985] as being capable of causing 153 
platelet activation, 0.5 to 1.2nM of thrombin (0.05 to 0.12U/ml) . The equations of the model 154 
are shown in Table 1. The initial values for the reaction rate constants, shown in Table 2, are 155 
taken either from already existing models or from experimental studies. 156 
As the proposed model used a reduced number of 4 reactions, each reaction rate represents 157 
the integral effect of more than one actual process. Also, ‘activated platelets’ actually 158 
represent platelet activity, in the sense that 100% activated platelets implies maximum 159 
platelet activity rather than the fact that all platelets are activated. Figure 1a illustrates the 160 
actual biochemical reactions that influence each constant while Figure 1b the reduced model. 161 
The model is structured as follows: During the initiation phase thrombin generation is 162 
described by a slow first order reaction. This reaction, which is localized on the TF-bearing 163 
cells, is used to describe the whole pro-coagulant activity that occurs on the TF-bearing cells 164 
– formation of the TF-VIIa complex, activation of factors IX, X and V. In this reaction is also 165 
included the inhibition of the amounts of IXa, Xa that leave the cell surfaces by TFPI in 166 
plasma. The initial value for the reaction rate constant was estimated using the lag times 167 
reported in [Lawson, Kalafatis et al. 1994; van't Veer and Mann 1997]. Inhibition of thrombin 168 
during this phase is also modelled as a first-order reaction, with the value of the reaction rate 169 
constant for thrombin inhibition calculated from the IIa ∙ATIII inhibition reaction, using the 170 
initial bulk concentration of ATIII                                     , as this 171 
reaction is the major process of thrombin inhibition .(Thrombin inactivation is 77% by anti-172 
thrombin, 14% a2 macroglobulin and 9% by minor inhibitors [Hemker and Béguin 1995]). 173 
With this setup for the initiation phase, the model describes the threshold behaviour of the 174 
initiation of blood coagulation in respect to TF concentration[Okorie, Denney et al. 2008; 175 
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Shen, Kastrup et al. 2008], as there is a minimum value of activation constant capable of 176 
causing thrombin burst and, as this constant is related to the TF concentration (see 177 
discussion), a threshold value for TF concentration.  178 
Beyond the point that thrombin concentration has reached the threshold value, the conversion 179 
of prothrombin to thrombin is mainly attributed to platelets after their activation. This process 180 
is modelled as a second-order reaction, with the initial values for the reaction rate constant 181 
used from [Rosing, van Rijn et al. 1985; Sorensen, Burgreen et al. 1999]. Platelets can be 182 
activated either by thrombin, if its concentration is greater than the threshold value, or 183 
directly by other activated platelets. Thrombin in concentration about 1nM can initiate the 184 
activation of platelets [Liu, Freedman et al. 1994], from 0.5nM for minimum activity to 185 
1.2nM for maximal [Rosing, van Rijn et al. 1985]. Platelet activation by thrombin is 186 
modelled as a first-order reaction that is initiated when thrombin concentration reaches the 187 
threshold value. The activation of platelets by activated platelets represents the activation by 188 
platelet-released substances and is modelled as a second order reaction. the reaction rate 189 
constants for the activation of platelets used were found in [Kuharsky and Fogelson 2001]. In 190 
the case of TF induced coagulation the contribution of the later reaction is negligible, but it 191 
can make the model capable of being used to describe shear induced coagulation. 192 
 193 
Inhibition of thrombin during the propagation phase is again modelled as a first-order 194 
reaction. The reaction rate constant for the inhibition of thrombin in plasma is not the same as 195 
for the initiation phase; here we must note that this constant is significantly smaller than the 196 
one used in [Leiderman and Fogelson 2011] for modelling this reaction in the same manner, 197 
which was based on thrombin half-life in plasma. However, as the activation of protein C that 198 
acts as an inhibitor to the coagulation process mainly occurs on the endothelium cells, for the 199 
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areas near the endothelium cells the value used for thrombin inhibition is larger, with the 200 
exact value derived from the adjustment of the model with the use of TGA results. As 201 
demonstrated in Figure 2, the model using the initial parameter values gives reasonable 202 
results. By adjusting the values of the constants and parameters of the model within 203 
physiological limits, the model can reproduce, to a good level of accuracy, actual thrombin 204 
production, by considering the four main parameters of a thrombin generation assay: lag-time 205 
(Tlag), maximum concentration (Cmax), time until thrombin concentration reaches the 206 
maximum (Tmax) and the estimated thrombin potential (ETP); the last one is represented by 207 
the surface under the curve in a thrombin concentration vs time graph. The initial attempts of 208 
adjustments were performed manually, but in general the adjustment can be done using the 209 
following procedure and assumptions. 210 
Platelet response is very fast compared to the other processes included in the model 211 
[Frojmovic, Mooney et al. 1994; Frojmovic, Mooney et al. 1994]. With the approximation 212 
that all platelets are activated as soon as thrombin concentration reaches the threshold value, 213 
the system of the equations can be analytically solved, giving the equation that describes 214 
thrombin concentration through time. This equation has the general form (see appendix 1a):  215 
                                 
The equation is similar to the equation proposed in [Wagenvoord, Hemker et al. 2006] but in 216 
a non-uniform platelet distribution the results will vary in space. Here the constants A, B and 217 
C depend both on the model parameters and TAG results, and they have different values for 218 
the initial phase and the propagation phase. 219 
Using the parameters of the TGA and this function we obtain the equations 220 
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From this set of equations the constants of the model can be approximated numerically, 221 
making the resulting model equations able to reproduce with the curve of a TGA with given 222 
parameters. In most of the following results only the constants related to thrombin production 223                 (see Table 1) were adjusted. In case data from the whole curve is available, 224 
the constants can be approximated as described in appendix 1b. 225 
Results 226 
We first applied the model using the initial values for the constants; while the resulting curve 227 
has the shape of a typical thrombin generation curve, the actual values were significantly 228 
higher than the typical results of TGA for fresh platelet rich plasma as reported in 229 
[Gerotziafas, Depasse et al. 2005]. Performing simulations for different time steps, we found 230 
that the results of the model are identical for time steps below 0.5s (Figure 2). As a whole 231 
heart cycle at rest conditions is about 0.8s (for 75 bpm), the maximum magnitude of the time 232 
steps for simulating pulsating flow is much smaller, thus in terms of temporal discretization, 233 
the coupling of the model with CFD simulations can be straightforward.  234 
Subsequently we applied the model in 8 different cases, denoted as Case1-8. In the plots, 235 
when both model and experimental results are represented, model results are named ‘C# 236 
model’ and the experimental results ‘C# exp’. The equations for the adjustment of the 237 
constants were solved in MATLAB, while the adjustment of the platelet related constants was 238 
done manually using Excel and Systems Biology Toolbox 2 [2006]. Case 1 represents the 239 
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tuning of the model constants in order to reproduce typical TGA results as reported in 240 
[Gerotziafas, Depasse et al. 2005] and the resulting curve (C1 model) is shown in Figure 3 241 
and Figure 4, compared with curves representing slower thrombin generation. In the absence 242 
of inhibition (case 2 and case 3), the time interval between the end of the initiation phase and 243 
the moment that thrombin concentration reaches its maximum value is 2-4 min, depending on 244 
the constant for thrombin activation by activated platelets, and the results match 245 
approximately the experimental thrombin production curves found in [Lawson, Kalafatis et 246 
al. 1994] (Figure 5).  247 
The next test (Case 4) involved adjusting the model constants in order to fit an arbitrary 248 
thrombin generation curve. The experimental curve was found in [Hemker, Giesen et al. 249 
2003]. Figure 6, shows that the model predicts the experimental curve with good accuracy. 250 
For future application of the model under flow conditions characterised by non-uniform 251 
concentrations of platelets, it has been considered important to test its behaviour with given 252 
constants for varying concentration of platelets near to the physiological values. We adjusted 253 
the constants so that the model approximated the TGA results for platelet concentration 150 x 254 
109 pl/L (physiological values are 200-400 x 109 pl/L) and then applied the model with the 255 
same setup for two other values of platelet concentrations; Cases 5-7 use the same values for 256 
reaction rate constants with platelet concentration 400, 150 and 100 x 109 pl/L respectively. 257 
The results shown on Table 3 are within the range of values reported in [Gerotziafas, Depasse 258 
et al. 2005] although the dependence of maximum concentration of thrombin on platelet 259 
concentration seems a little stronger than for the in vitro experiments. The resulting curves 260 
are shown in Figure 3. Further increase of platelet concentration resulted in higher values for 261 
maximum thrombin concentration and small decrease of Tmax, without significant effect on 262 
ETP. If the constants describing platelet activation are also suitably modified, the equations 263 
can match curves that depict slower thrombin formation like the ones reported in [Allen, 264 
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Wolberg et al. 2004] for lower platelet concentrations (75 x 109 pl/L) as shown in Figure 4. 265 
The values of the model constants after modification, in order to fit different cases, are shown 266 
in Table 4 and for all cases the values are within a reasonable range. 267 
Discussion  268 
This work presents a phenomenological model for thrombin generation that is flexible 269 
enough to reproduce a wide range of cases and simple enough to be used for modelling 270 
thrombin generation in large scale CFD simulations  in contrast with the most recently 271 
suggested models. The four equations of the model are based on the principle assumption that 272 
all reactions occur either on the platelet surface or on the reacting site of the vessel wall. 273 
The reactions related to platelet activation actually represent the transition from the initiation 274 
to the propagation phase. As the curves used to reproduce a wide range of TGA results 275 
correspond to different experiments, these constants vary significantly between two groups of 276 
Cases. In the experiments for Cases 1-4, where phospholipids have been used as a substrate 277 
for enzymatic reactions, this transition is much faster than for Cases 5-8 where human 278 
platelets have been used. For Cases 5-8 the values of these constants have been adjusted 279 
manually. It is interesting that the calculated time until platelets reach half of the maximum 280 
activity for Case 8 is 5-10 min, in agreement with [Allen, Wolberg et al. 2004]. However, as 281 
reported recently [Ninivaggi, Apitz-Castro et al. 2012], TGA results in whole blood resemble 282 
the curves of Case 1 and 4, (possibly because red blood cells that are not included in most 283 
TGA also contribute to thrombin generation [Ninivaggi, Apitz-Castro et al. 2012; Whelihan 284 
and Mann 2013] ) so this modification of the parameters related to platelet activation is not 285 
necessary for physiological cases and the model can be calibrated as described above. On the 286 
other hand with the use of this modification the model could also approximate pathological 287 
cases as haemophilia or thrombin generation after anticoagulation treatment. In contrast to 288 
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the methods described and reviewed in [Brummel-Ziedins 2013] where the effect of the 289 
variation of each factor concentration and activity is investigated, this model uses only the 290 
information included in the TGA curve, thus it has some limitations. For a given value of 291 
inhibition reaction rate, has a maximum lag time that it can reproduce if the reported lag time 292 
is greater than this maximum value, modification of the inhibition constant is required. 293 
Curves corresponding to pathological situations as severe haemophilia A [Wagenvoord, 294 
Hemker et al. 2006]) can be approximated. As factor VIII is mainly involved in the 295 
propagation phase, it is expected that in order to reproduce curves for different fVIII 296 
concentrations the related constants (                       should be modified. As shown in 297 
Figure 8, this can by done ( (the concentrations of VIII have been calculated using 12.8 hours 298 
as half-life of fVIII [van Dijk, van der Bom et al. 2005]). `At first sight, the most significant 299 
inaccuracy of the model (when the initial values of the parameters are used) is that the time 300 
interval between the initiation of thrombin burst and maximum concentration of thrombin is 301 
smaller than the one reported in TGAs (2.8min compared to 2min predicted by the model) 302 
when adjusting only the three previously mentioned parameters. The increase of thrombin 303 
concentration predicted by the model is sharper compared to the experimental data and the 304 
shapes of the two curves differ for this time interval. That can be fixed by adjusting manually 305 
the constants related to platelet activation as we did for Cases 4-8. However the experimental 306 
data, while in all studies presented in the form of curves, in some cases actually correspond to 307 
measurements in discrete time intervals and the resulting curves are obtained through data 308 
fitting. In Figure 7 a plot of three curves is shown, for the time interval of thrombin 309 
concentration increase, obtained from the same model results. In one case (dense) the time 310 
interval between two data points is 2s, while for the other two cases (sparse1 and sparse2) is 311 
30s and 20s respectively –reasonable time intervals between the withdrawal of two samples. 312 
It is obvious that curve fitting on experimental values, used in studies prior to the introduction 313 
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of continuous monitoring of thrombin generation, while making the results more presentable 314 
can also give incorrect information on the actual evolution of the process between two 315 
measurements, so differences between modelled and experimental curves do not necessary 316 
indicate inadequacy of the model. 317 
The constant that represents the initial thrombin production rate ksurf (for a given value of the 318 
inhibition rate) is mainly determined by the lag time. While there is dependence of different 319 
experiments’ results on the exact composition of the samples and the triggering substance 320 
used, for the case described in [van't Veer and Mann 1997; Gerotziafas, Depasse et al. 2005], 321 
there seems to be a clear relationship (R2=0.989) between TF concentration and ksurf  for the 322 
same experimental conditions and TF concentrations between 1 and 30pM: 323 
                                   
The constant values are                    while for the aforementioned study the 324 
maximum calculated value for the rate of thrombin generation during the initiation phase is 325                      and the relationship can approximately be written as: 326 
                                         
These relationship gives good result when estimating ksurf in other studies with similar 327 
methodology, but for studies using recombinant TF:VIIa as trigger for the coagulation 328 
process, while the a good correlation between ksurf and trigger concentration can be 329 
established, (R2>0.98) the resulting formulas are different.  330 
For the case of thrombus formation on a reacting site of a blood vessel wall, the term 331 
representing the slow phase of thrombin generation corresponds to a surface reaction term. 332 
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The reaction rate for the surface reaction can be calculated with the use of the reported 333 
surface TF concentration in atheromatous plaques (33pg/cm2) [Bonderman, Teml et al. 2002] 334 
and the molecular weight of (46,000Da approximately [Arabinda Guha 1986]). For a 335 
computational cubic cell of e.g. 100μm this numbers would lead to a TF concentration of 336 
about 70pM resulting to                   . Sub-threshold concentration of thrombin 337 
actually represents also the products of the previous steps of coagulation. At the same time 338 
this approach allows a slow rate of fibrin production before the burst of thrombin and a 339 
realistic prediction of clotting time. As TGA results demonstrate inter-laboratory variation 340 
[Van Veen, Gatt et al. 2008], this model, based on TGA results and with its simplified 341 
character, does not claim to reproduce with precise accuracy thrombin generation but offers a 342 
way to model thrombin generation that (1) has comparative value, in the sense that it can be 343 
adjusted to describe different rates of thrombin generation, and (2) can be easily coupled with 344 
CFD simulations. We believe that these equations, if combined with two more, one 345 
describing fibrin formation and one describing platelet deposition on the reacting site of the 346 
vessel, can be used as a thrombus formation model for three dimensional CFD simulations in 347 
blood vessels. The results of such a model can be used to compare the evolution of thrombus 348 
formation in different cases and for different thrombogenic potential of human blood. Finally, 349 
as the model describes the production of thrombin in blood in a phenomenological way, it 350 
does not require additional information regarding the concentration of different factors and 351 
the details for every reaction in the coagulation system and it can be calibrated and applied 352 
directly for different cases based only on the parameters or the curve of the TGA (or the 353 
curve itself). 354 
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 524 
 Appendix: Equations’ solution: 525 
a. Under the assumption that all platelets are instantly activated when thrombin reaches 526 
its threshold value, the concentration of platelets is zero when thrombin concentration 527 
is below the threshold value and equal to the resting platelet concentration when 528 
thrombin exceeds the threshold values. The equations describing thrombin and 529 
prothrombin concentration become: 530                                                 
Here ktot represent the total rate of prothrombin conversion to thrombin and includes both the 531 
production on the reacting site and on the platelet surfaces: 532 
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This leads to a direct solution for prothrombin concentration: 533 
                           
The D.E. describing thrombin concentration becomes: 534 
                                                                                          
The equation can be rewritten as follows, 535 
                               
The last expression, after manipulation leads to an (approximate because of the aforementioned 536 
assumption) analytic solution for the temporal evolution of thrombin concentration (X): 537 
                                             
                                                                                         
 538 
For               the equation gets the simplified form: 539 
                                             
b. In the case the data from the whole curve is available, there is another way for 540 
obtaining the model constants. The reaction rate is obtained by solving (numerically) 541 
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the last equation: 542                                                        
As the activated platelet concentration is approximately, 543                                         
Analytical expression can be obtained for prothrombin concentration versus time, 544                                and therefore for the differential equation 545 
describing thrombin evolution for t>Tlag,                                      546 
and the constants can be obtained numerically using an iterative process. 547 
List of Figures 548 
Figure 1: Schematic representation of cell based model for blood coagulation (reproduced 549 
from Smith et al 2009). (a) and the reduced model (b). The different coloured arrows 550 
represent the actual processes that are lumped in each reaction rate constant . Red: 551 
Inhibition of thrombin in plasma by ATIII and near the vessel wall by APC. Green: Platelet 552 
activation by thrombin. Purple: thrombin production by activated platelets. Yellow: 553 
Thrombin production in plasma near the reacting site on vessel wall, includes all the reactions 554 
from binding of VIIa on TF up to the generation of small amounts of IIa and also (mostly) the 555 
inhibition of all other species except thrombin. Turquase: Activation of platelets by 556 
substances released by activated platelets such as ADP.  557 
Figure 2: Results of the model for different time steps. For time steps below 0.5s the results 558 
coincide. 559 
Figure 3: Behaviour of the model for different initial platelet concentrations. 560 
Figure 4: Adjustment of the model in order to reproduce slower thrombin generation, 561 
experimental data.1 562 
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Figure 5: Model results for thrombin production without inhibition, adjusted to fit the results 563 
reported in27 564 
Figure 6: Capability of the model to reproduce an arbitrary thrombin generation curve20 565 
Figure 7: Dependence of the shape of the curve on the time interval between two data 566 
points. While the initial results are the same curve fitting on data produces significantly 567 
different curves 568 
Figure 8: Reproduction of thrombin generation curves corresponding to different fVIII 569 
concentrations and the normalized modification of the related constants. 570 
  571 
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Tables, figures 572 
Table 1: Equations of the model 573 
  574 
Thrombin (IIa)                                            
Prothrombin (II)                                  
Activated Platelets (AP)                                     
Resting Platelets (RP)                                      
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Table 2: Constants and parameters 575 
  576 
Process Constant 
symbol 
Initial value (S.I.)) Reference 
 
Thrombin generation by 
activated platelets 
                     
[Rosing, van Rijn 
et al. 1985; 
Sorensen, Burgreen 
et al. 1999] 
Thrombin generation on 
reacting surface  
              n/a 
Platelet activation by 
thrombin 
                                                   [Kuharsky and Fogelson 2001] 
Platelet activation by 
activated platelets 
                   [Kuharsky and 
Fogelson 2001] 
Thrombin inhibition*                      
[Hockin, Jones et 
al. 2002; 
Leiderman and 
Fogelson 2011] 
Thrombin concentration 
threshold for platelet 
activation 
                             
(0.5-1.2nM or 0.05-0.12U/ml) 
[Rosing, van Rijn 
et al. 1985] 
26 
Papadopoulos et al-Model for thrombin generation 
 
 
Table 3: Results of the model for different cases 577 
  Tlag (min) Tmax (min) Cmax (nM) ETP (nM∙min) 
Case 1 
experiment 3.6 ± 0.8 7.4±1.8 164±50 1321±330 
model 3.7 6.8 165 1364 
Case 2 
experiment 1.5 3.5 (1.5∙103) n/a 
model 1.5 4 (1.5∙103) n/a 
Case 3 
experiment 0.67 2.25 (1.5∙103) n/a 
model 0.65 2.38 (1.5∙103) n/a 
Case 4 
experiment 3.5 4.8 199 735 
model 3.7 4.6 196 710 
Case 5 
experiment 5±0.5 11±2.7 161±38 1633±81 
model 5.8 9 190 1718 
Case 6 
experiment 5.5±0.5 11±0.2 98±40 1316±255 
model 6 9.4 91 1370 
Case 7 
experiment 5.8±0.7 13±0.9 72±38 1135±300 
model 6 9.6 62 1118 
Case 8 
experiment 15 27 101 2012 
model 13.3 25.3 102 1934 
 578 
  579 
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 580 
Table 4: The variation of the model constants after adjustment in order to reproduce different 581 
cases 582 
Constant 
Initial 
estimations 
Case 1 Case 2 Case 3 Case 4 Cases 5-7 Case 8  
           10-5 7.367∙10-6 9.162∙10-6 1.511∙10-5 7.367∙10-6 7.223∙10-6 4.06∙10-7                        0.73 2.8 4 1.55 0.525 3.6 
                       0.032 0 0 0.052 0.0262 0.024                     - - 0.5 0.5 0.002 0.0018 
 583 
Figure 1a 584 
 585 
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Figure 1b 586 
 587 
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Figure 2 588 
 589 
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Figure 3 590 
 591 
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Figure 4 592 
 593 
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Figure 5 594 
 595 
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Figure 6 596 
 597 
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Figure 7 598 
 599 
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Figure 8 600 
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